InvestorsHub Logo
Followers 0
Posts 158
Boards Moderated 0
Alias Born 12/11/2016

Re: abew4me post# 46612

Sunday, 06/11/2017 12:07:30 AM

Sunday, June 11, 2017 12:07:30 AM

Post# of 58862
If you are going to manufacture DNA you manufacture a specific sequence. Manufacturing DNA in general without a sequence is akin to an orchestra playing random notes. You can manufacture DNA through biosynthesis which requires no template or through PCR which requires a template. One way or another you end up with some junk DNA (impurities) which is removed during purification. In the end the product is the same. It has to be. I hate to say it but APDN claiming that their PCR process is superior to others is probably nonsense. If it were superior the only difference would have been cost, meaning that the yield is higher or somehow the process is faster, cheaper, whatever.
When I say commodity, I mean that hundreds of manufacturers can manufacture the exact same product: a sequence specified by the customer. I did not say it is cheap. But since it is a commodity, competition is really around cost, and possibly lead time. Nothing else.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent APDN News